The UTR mutation of DDIT4 is involved in autophagy of pancreatic cancer cells by regulating the expression of DDIT4, and it may be a potential biomarker for chemotherapy resistance and poor prognosis. Here, DDIT4 is linked to familial pancreatic carcinoma.